Showing 8,581 - 8,600 results of 20,793 for search '"Therapy"', query time: 0.13s Refine Results
  1. 8581

    Heterotopic Gastric Mucosa in Cervical Oesophagus: Clinical Observations by A. I. Dolgushina, A. O. Khikhlova, E. R. Olevskya, O. V. Naumenko, S. Yu. Belousov

    Published 2021-04-01
    “…For several years she was visiting an otorhinolaryngologist and psychotherapist, with therapy ineffective. Esophagogastroduodenoscopy (EGDS) at the last visit revealed several foci of HGM in cervical oesophagus of 1.2 x 0.8 cm maximal size. …”
    Get full text
    Article
  2. 8582

    Secondary Trigeminal Neuralgia after a Brainstem Hemorrhagic Stroke with Adverse Reaction to Carbamazepine: A Case Report by I Gusti Agung Ayu Andra Yusari, Ida Ayu Sri Wijayanti, Ketut Widyastuti, I Made Oka Adnyana

    Published 2024-12-01
    “…She experienced severe adverse reactions with the first-line pharmacological therapy, carbamazepine and gabapentin. Fluoxetine was given as an alternative therapy, and the patient began to experience improvement in the pain intensity and frequency within a few weeks. …”
    Get full text
    Article
  3. 8583

    Future Prospects in the Diagnosis and Management of Localized Prostate Cancer by Ahmet Tefekli, Murat Tunc

    Published 2013-01-01
    “…Current definitive treatment options for clinically localized PCa with functional and oncological success rates up to 95% include surgery (radical prostatectomy), external-beam radiation therapy, and interstitial radiation therapy (brachytherapy). …”
    Get full text
    Article
  4. 8584

    Delirium with Concurrent Use of Lithium and ECT and the Safety Implications: Case Reports and Review of the Literature by Mustafa Ali, Barikar C. Malathesh, Seshadri Sekhar Chatterjee, Soumitra Das, Prakriti Pokhrel, Mary Elizabeth Trejo Hernandez, John C. Murnin

    Published 2023-01-01
    “…Additionally, alterations in blood-brain barrier permeability, such as those caused by electroconvulsive therapy and age, increased the likelihood of delirium. …”
    Get full text
    Article
  5. 8585

    N2GNet tracks gait performance from subthalamic neural signals in Parkinson’s disease by Jin Woo Choi, Chuyi Cui, Kevin B. Wilkins, Helen M. Bronte-Stewart

    Published 2025-01-01
    “…Abstract Adaptive deep brain stimulation (DBS) provides individualized therapy for people with Parkinson’s disease (PWP) by adjusting the stimulation in real-time using neural signals that reflect their motor state. …”
    Get full text
    Article
  6. 8586

    A Comprehensive Updated Review of Pharmaceutical and Nonpharmaceutical Treatment for NAFLD by Newaz Hossain, Pushpjeet Kanwar, Smruti R. Mohanty

    Published 2016-01-01
    “…This review focuses on the available evidence on pharmaceutical and nonpharmaceutical therapy in the treatment and the prevention of NAFLD, primarily NASH.…”
    Get full text
    Article
  7. 8587

    Neuronal Differentiation of Adipose Derived Stem Cells: Progress So Far by T. J. Moore, Heidi Abrahamse

    Published 2014-01-01
    “…However, none of these strategies have yet been able to produce a fully functional descendent suitable for use in stem cell therapy. Due to the positive effects that low level laser irradiation has shown in stem cell studies to date, we propose that it could enhance the processes involved in the differentiation of adipose derived stem cells into neuronal lineages.…”
    Get full text
    Article
  8. 8588

    Preparation and Synergistic Anti-Tumor Effect of Iridium Oxide Nanocomposites under Microscope by Xudong He, Feng Xiang, Zhangyi Xu

    Published 2022-01-01
    “…At the same time, IrOx, as a sound-sensitive agent, can produce ROS under US irradiation, amplify intracellular oxidative stress, accelerate tumor cell death, and finally achieve the effect of SDT chemotherapy synergistic therapy. The experimental results show that IrOx@DOX has the dual response of pH and US, and the inhibition rates are 27%, 57%, and 76%, respectively. …”
    Get full text
    Article
  9. 8589

    Personalized approach in the management of women with heart failure with preserved ejection fraction and carbohydrate metabolism disorders by L.R. Petrovska, I.O. Kostitska, T.R. Petrovskyy, R.V. Petrovskyy

    Published 2024-12-01
    “…According to the design of the scientific study, all patients at the beginning and after 12 weeks of therapy underwent assessment of basic anthropometric data, a set of laboratory examinations, clinical and instrumental diagnosis. …”
    Get full text
    Article
  10. 8590
  11. 8591

    Bexarotene-induced hypothyroidism and dyslipidemia; a nation-wide study by Katsunori Manaka, Junichiro Sato, Yusuke Hikima, Hirofumi Horikoshi, Maho Taguchi, Akimichi Morita, Hiraku Suga, Hikari Boki, Taku Fujimura, Yoji Hirai, Takatoshi Shimauchi, Chiharu Tateishi, Eiji Kiyohara, Ikko Muto, Hideki Nakajima, Riichiro Abe, Kazuyasu Fujii, Chikako Nishigori, Eiji Nakano, Kentaro Yonekura, Takeru Funakoshi, Masahiro Amano, Tomomitsu Miyagaki, Reiko Yamashita, Makoto Sugaya, Toshihisa Hamada, Masaomi Nangaku, Taroh Iiri, Noriko Makita

    Published 2024-08-01
    “…Central hypothyroidism and dyslipidemia are well-known adverse events (AEs) of bexarotene therapy. Although hypothyroidism is known to cause dyslipidemia, no study has examined the association between hypothyroidism and dyslipidemia in patients undergoing bexarotene therapy. …”
    Get full text
    Article
  12. 8592

    Pain in Women by Anita M Unruh

    Published 2008-01-01
    Get full text
    Article
  13. 8593
  14. 8594

    Evaluating the effects of continuous veno-venous hemodiafiltration on O2 and CO2 removal and energy expenditure measurement using indirect calorimetry by Weronika Wasyluk, Robert Fiut, Marcin Czop, Agnieszka Zwolak, Wojciech Dąbrowski, Manu L N G Malbrain, Joop Jonckheer

    Published 2025-01-01
    “…This study aims to evaluate the effects of CVVHDF on O₂ and CO₂ removal and the accuracy of REE measurement using IC in patients undergoing continuous renal replacement therapy. Design Prospective, observational, single-center study. …”
    Get full text
    Article
  15. 8595

    Cryoablation combined with dual immune checkpoint blockade enhances antitumor efficacy in hepatocellular carcinoma model mice by Jun Gu, Zepeng Yu, Xiangxiang Tang, Wenying Chen, Xuedong Deng, Xiaoli Zhu

    Published 2024-12-01
    “…Local T-cell infiltration in right tumor tissues increased after the combination therapy, while the number of immunosuppressive cells was significantly reduced. …”
    Get full text
    Article
  16. 8596

    Hyponatremia due to preserved non-osmotic arginine vasopressin secretion in adipsic diabetes insipidus: a case report with review of literature by Yasufumi Seki, Shun Sugawara, Saya Suzuki, Yulia Minakuchi, Kazuhisa Kusuki, Yuzo Mizuno

    Published 2024-11-01
    “…Hyponatremia observed in patients with ADI has been considered a complication of desmopressin therapy. Herein, we present a case of impaired thirst sensation and arginine vasopressin (AVP) secretion without desmopressin therapy, in which hyponatremia developed due to preserved non-osmotic AVP secretion. …”
    Get full text
    Article
  17. 8597

    Osteomyelitis in Cat-Scratch Disease: A Never-Ending Dilemma—A Case Report and Literature Review by D. Donà, L. Nai Fovino, E. Mozzo, G. Cabrelle, G. Bordin, R. Lundin, C. Giaquinto, T. Zangardi, O. Rampon

    Published 2018-01-01
    “…Most patients had excellent prognosis; in particular, all patients not receiving any therapy showed complete recovery and no recurrence of symptoms. …”
    Get full text
    Article
  18. 8598

    Sarcopenia in IBD patients and the role of nutritional and physical activity interventions in its management – a systematic review by Michalina Jurkiewicz, Karolina Siembab, Julia Białeta, Katarzyna Rowińska, Agnieszka Napieralska, Wiktor Garbarczyk, Albert Kapla, Alicja Černohorská, Daria Bednarczyk, Wiktoria Pysiewicz

    Published 2025-02-01
    “…Sarcopenia and pre-sarcopenic conditions are important to be diagnosed and maintained in the course of IBD, as they exert detrimental impact on the therapy outcomes. There is increased probability of therapy failure such as change of pharmacotherapy, hospitalization or surgical intervention, in individuals with sarcopenia. …”
    Get full text
    Article
  19. 8599

    Assessment of patient satisfaction and adherence to treatment with IOP-lowering medication in an innovative OSD bottle by D.P. Novikov, E.S. Kuznetsova

    Published 2023-11-01
    “…When asked about continuing therapy, most respondents answered that they wanted to continue treatment with the prescribed drug. …”
    Get full text
    Article
  20. 8600

    Detection of Mycobacterium tuberculosis DNA in intraocular fluid of 11 suspected tuberculous uveitis patients by multiplex PCR by Huirong Xu, Min Xu, Fang Chen, Hong Chen, Wei Du, Jing Yu

    Published 2025-01-01
    “…The average duration of antituberculosis therapy administered to the 11 patients was 7.1 months (range: 6–10 months). …”
    Get full text
    Article